Prognostic Significance and Determinants of Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance in Acute Reperfused Myocardial Infarction

Journal of the American College of Cardiology

Volumn 55, Issue 22, 2010, Pages 2470-2479

  Eitel, Ingo ^a   Desch, Steffen ^a   Fuernau, Georg ^a   Hildebrand, Lysann ^a   Gutberlet, Matthias ^a   Schuler, Gerhard ^a   Thiele, Holger ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

cardiovascular magnetic resonance; magnetic resonance imaging; myocardial infarction; myocardial salvage; prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DEATH; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952512632     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.049     Document Type: Article

References (30)

1. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?. Circulation 79 (1989) 441-444
2. Gibbons R.J., Christian T.F., Hopfenspirger M., Hodge D.O., and Bailey K.R. Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention. J Am Coll Cardiol 24 (1994) 616-623
3. Gibbons R.J., Miller T.D., and Christian T.F. Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: a measure of the efficacy of therapy in acute myocardial infarction. Circulation 101 (2000) 101-108
4. Kastrati A., Mehilli J., Dirschinger J., et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 359 (2002) 920-925
5. Kastrati A., Mehilli J., Nekolla S., et al. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol 43 (2004) 734-741
6. Schomig A., Kastrati A., Dirschinger J., et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 343 (2000) 385-391
7. Ndrepepa G., Mehilli J., Schwaiger M., et al. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med 45 (2004) 725-729
8. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
9. Aletras A.H., Tilak G.S., Natanzon A., et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 113 (2006) 1865-1870
10. Friedrich M.G., Abdel-Aty H., Taylor A., Schulz-Menger J., Messroghli D., and Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1581-1587
11. Wright J., Adriaenssens T., Dymarkowski S., Desmet W., and Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. J Am Coll Cardiol Img 2 (2009) 825-831
12. Carlsson M., Ubachs J.F., Hedstrom E., Heiberg E., Jovinge S., and Arheden H. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. J Am Coll Cardiol Img 2 (2009) 569-576
13. Thiele H., Sareban M., Engelhardt H., Eitel I., Gutberlet M., and Schuler G. Reproducibility of myocardial salvage in acute myocardial infarction by the use of contrast-enhanced magnetic resonance imaging (abstr). Circulation 120 Suppl (2009) 300
14. van de Werf F., Bax J., Betriu A., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29 (2008) 2909-2945
15. Schroder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 110 (2004) e506-e510
16. Ganame J., Messalli G., Dymarkowski S., et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 30 (2009) 1440-1449
17. Bondarenko O., Beek A.M., Hofman M.B., et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 7 (2005) 481-485
18. Kastrati A., Mehilli J., Dirschinger J., et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 359 (2002) 920-925
19. Thiele H., Kappl M.J., Conradi S., Niebauer J., Hambrecht R., and Schuler G. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 47 (2006) 1641-1645
20. Eitel I., Desch S., Sareban M., et al. Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty. Am Heart J 158 (2009) 806-813
21. Lee J.T., Ideker R.E., and Reimer K.A. Myocardial infarct size and location in relation to the coronary vascular bed at risk in man. Circulation 64 (1981) 526-534
22. Tilak G.S., Hsu L.Y., Hoyt Jr. R.F., Arai A.E., and Aletras A.H. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol 43 (2008) 7-15
23. Wu K.C., Zerhouni E.A., Judd R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97 (1998) 765-772
24. Hombach V., Grebe O., Merkle N., et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 26 (2005) 549-557
25. Nijveldt R., Beek A.M., Hirsch A., et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 52 (2008) 181-189
26. Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 104 (2001) 636-641
27. Nallamothu B.K., Bradley E.H., and Krumholz H.M. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 357 (2007) 1631-1638
28. Reimer K.A., Lowe J.E., Rasmussen M.M., and Jennings R.B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56 (1977) 786-794
29. Gersh B.J., Stone G.W., White H.D., and Holmes Jr. D.R. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?. JAMA 293 (2005) 979-986
30. Francone M., Bucciarelli-Ducci C., Carbone I., et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 54 (2009) 2145-2153